Position
Squarepoint Ops LLC in Rocket Pharmaceuticals Inc
Back to the book · All holders of ROCKET PHARMACEUTICALS INC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.03K$3.51 → $3.58
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 68.3K | $239.8K | — | — | — | 0.0% |
| Q1 2026 | 29K | $103.8K | $3.58 | $2.03K | −$138.1K | 0.0% |